Surgery and new Pharmacological strategy in some atherosclerotic chronic and acute conditions

Luisetto, M

doi:10.29328/journal.ascr.1001006

Arch Surg Clin Res 2017

DOI: 10.29328/journal.ascr.1001006

|View full text |Cite

Surgery and new Pharmacological strategy in some atherosclerotic chronic and acute conditions

M Luisetto¹

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

2018

Publication Types

Select...

Article2

Relationship

Self Cite2

Independent0

Authors

Journals

Cited by 2 publications

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

New pharmacological strategies in some metabolic endocrine disorder under a toxicological approach

Luisetto¹

2017

Ann Clin Endocrinol Metabol

Self Cite

View full text Add to dashboard Cite

In this review After Observing biomedical literature (starting from some heart disease) results that some pathological phenomena are deeply involved in some metabolic endocrine condition: Kinetics and gradients in metabolism, catabolism, time related, toxic like effect, electrical cell membrane status, smooth vascular muscle cell hyper-reactivity, platelet iperactivations, central autonomic control after acute stroke, great electrolytes unbalances et other factors as pro-hypertrophic signaling and oxidative stress. Observing actual current therapy in some metabolic endocrine therapy often is used association of drugs (in example in type II diabetes). In Many other pathologies effi cacy drug therapy exist, and often only 1 pharmacological molecule resolve the pathological condition. But in many disease even associating 2-3-4 drugs the % of cure not increase (effi cacy, effectiveness). It mean that this drugs strategies are not the really best? Or it mean a low active level? Why for this pathological condition this association drugs in currently use not do the right works as really needed? There is the need for new really effi cacy drugs strategy that show a profi le of effi cacy as requested in order to resolve the pathological condition? Or to be added to the actual therapy? The actual pharmacological strategies in some metabolic endocrine disorder is really the best? Or other strategies can be introduced?

show abstract

New pharmacological strategies in some metabolic endocrine disorder under a toxicological approach

Luisetto¹

2017

Ann Clin Endocrinol Metabol

Self Cite

View full text Add to dashboard Cite

show abstract

Heart disease new hypothesis: under endogenous toxicological aspect

Luisetto¹

2018

J Cardiol Cardiovasc Med

Self Cite

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Surgery and new Pharmacological strategy in some atherosclerotic chronic and acute conditions

Cited by 2 publications

References 8 publications

New pharmacological strategies in some metabolic endocrine disorder under a toxicological approach

New pharmacological strategies in some metabolic endocrine disorder under a toxicological approach

Heart disease new hypothesis: under endogenous toxicological aspect

Contact Info

Product

Resources

About